Oridonin impedes breast cancer growth by blocking cells in S phase and inhibiting the PI3K/AKT/mTOR signaling pathway

Breast cancer is one of the most common cancers. Oridonin, a traditional Chinese medicine, is believed to inhibit tumor growth, but its particular effects on breast cancer remain unknown. In this study, we examined oridonin's effects on 4T1, MCF-7, and MDAMB-231 cellular activity using CCK8. Sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Weijie, Shi, Lei, Zhou, Wei, Liu, Xin, Xi, Yuan, Wang, Xinyin, Li, Ya, Xu, Xia, Tang, Youcai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372243/
https://www.ncbi.nlm.nih.gov/pubmed/37519735
http://dx.doi.org/10.1016/j.heliyon.2023.e18046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372243/
https://www.ncbi.nlm.nih.gov/pubmed/37519735
http://dx.doi.org/10.1016/j.heliyon.2023.e18046

Ejemplares similares